Literature DB >> 10427454

[Therapy of phantom pain with salmon calcitonin and effect on postoperative patient satisfaction].

C Simanski1, M Lempa, G Koch, T Tiling, E Neugebauer.   

Abstract

In this prospective clinical study we examined the intravenous application of salmon-calcitonin in eight patients with severe phantom limb pain (Visual Analogue Scale = 50-100). The patients presented at the Acute Pain Service (APS) section of the Second Department of Surgery, University of Cologne. Six of eight patients (75%) had no phantom limb pain after 10 days of intravenous treatment with salmon-calcitonin (maximum of five cycles of calcitonin infusion). Systematic follow-up examinations after 3, 6 and 12 months showed long-term success. Patient satisfaction was examined with a numeric rating scale (NRS 1-6) between the single infusion cycles. When patient satisfaction was low, the physician modified the time period or drug dosage between infusions. This study shows good or excellent results in patient satisfaction for six of eight patients (75%). A prospective randomized trial is required to verify the excellent results of intravenous salmon-calcitonin in a larger population. Alternative pharmacological and operative treatments of phantom limb pain are critically reviewed and assessed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427454     DOI: 10.1007/s001040050704

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

Review 1.  Regional pain syndromes in cancer patients.

Authors:  H A Zekry; E Bruera
Journal:  Curr Rev Pain       Date:  2000

2.  [Prolonged-release tapentadol for phantom pain. A case series].

Authors:  K-U Kern; P Bialas; D Fangmann
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.